Attacking the Cancer Cell: Advances in CAR T-Cell Therapy

Carlos Silva, MD and Elissa

Please join us as we speak about CAR T-cell therapy with Dr. Carlos Silva, a Moffitt Cancer physician at Memorial Healthcare System in Pembroke Pines, Florida. In this episode, we explore the latest advances and what the future holds for CAR T-cell therapy.   

This comprehensive view of CAR T-cell therapy will give blood cancer patients and their families hope. Through the utilization of targeted therapies, we can now see a future filled with better outcomes and potential cures.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this program is provided by: Allogene Therapeutics; Bristol Myers Squibb; CRISPR Therapeutics Ltd; Janssen Oncology & Legend Biotech; Kite, A Gilead Company and Novartis Pharmaceuticals Corp.


    1. Hi Karen,

      Thank you for your question. Currently, there are 6 FDA approvals for use of CAR T. However, there are many trials ongoing for other diagnoses. We encourage you to contact our Information Specialists at 800-955-4572 or They can also connect you with out Clinical Trial Support Center if you would like to look into CAR T trials you may be eligible for. You can more information about clinical trial support at

      Thank you for listening to The Bloodline! We hope this episode was helpful for you.

  1. Thank you so much for this information that was presented in a way that is understandable for patients. I have AML and understand that CarT Cell therapy is normt prescribed for AML, but like keeping up with what is currently being studied.

  2. Thank you for this extremely informative podcast on the CAR T Cell Transplant procedure. My husband is in the process of preparing for a CAR T Cell Transplant. This information is very much appreciated.

Leave a Comment

Your email address will not be published. Required fields are marked *